SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

JP Morgan Maintains Overweight on G1 Therapeutics, Lowers Price Target to $23

JP Morgan maintains G1 Therapeutics (NASDAQ:GTHX) with a Overweight and lowers the price target from $33 to $23.

Benzinga · 05/12/2020 15:21

JP Morgan maintains G1 Therapeutics (NASDAQ:GTHX) with a Overweight and lowers the price target from $33 to $23.